The same Cancer surgery through small cuts: less pain, a shorter hospital stay and a faster return to normal life, where it is safe for you.
For most of the history of Cancer surgery, treating a tumour meant a large incision, opening the abdomen, the chest, or the pelvis wide enough for the surgeon’s hands. The access was necessary. But the cost was significant: prolonged hospital stays, substantial post-operative pain, a recovery measured in months, and a wound across the body that was a daily reminder of what had happened.
Minimally invasive surgery changed this equation entirely. Instead of one large incision, three to four small ones, each less than a centimetre, allow a high-definition camera and precisely engineered instruments to enter the body. The surgeon operates with magnified, detailed vision on a monitor, with instrument control that is in many respects better to what the naked eye and bare hands can achieve in an open cavity.
Dr Dinesh Mavinahalli Gangaiah, MS, MCh (Surgical Oncology), has made minimally invasive surgery the foundation of his Cancer surgery practice at ARC Cancer Hospital, Bengaluru. His approach applies laparoscopic and robotic techniques to the full spectrum of GI, thoracic, gynaecological, and urological Cancer surgery, achieving the same Oncological completeness as open surgery, with the patient experience benefits that are no longer a luxury but an expectation of modern Cancer care.
India has approximately 14 lakh new Cancer cases diagnosed every year. Of these, a significant proportion, across GI, thoracic, gynaecological, and urological Cancers, are surgically treatable with curative intent, particularly when diagnosed at an early or locally advanced stage. Yet the majority of Cancer surgeries performed in India today are still open procedures, large incisions, prolonged hospital stays, and recovery times that delay the return to work, to family life, and to post-operative chemotherapy or radiation that may be necessary to complete treatment.
Minimally invasive surgery (MIS), also called laparoscopic surgery, keyhole surgery, or minimal access surgery, refers to any surgical approach that achieves the same surgical goals as open surgery through significantly smaller incisions, using specialised instruments and camera systems rather than direct open access.
In Cancer surgery specifically, MIS encompasses two main platforms:
Laparoscopic surgery uses 3 to 5 small incisions (5 to 12 mm each) through which a laparoscopic camera (laparoscope) and long-handled instruments are inserted. Carbon dioxide gas is used to inflate the body cavity, creating a working space. The surgeon operates while watching a high-definition monitor, with real-time visualisation of the surgical field at magnifications not achievable with the naked eye in open surgery.
VATS is the thoracic equivalent of laparoscopic surgery, small ports in the chest wall allowing a thoracoscope and instruments to perform lung resections, mediastinal procedures, and thoracic Oncology operations without the large incision of open thoracotomy. Instead of CO2 inflation, single-lung ventilation creates the working space in the chest.
Robotic surgery is the most advanced form of minimally invasive surgery, using a robotic surgical system to translate the surgeon’s hand movements into precise instrument movements inside the body, with 3D high-definition visualisation at 10 to 15 times magnification, and seven-degree-of-freedom instrument movement that exceeds what is possible with rigid laparoscopic instruments. The robotic speciality page covers this platform in detail, this page focuses on the broader principles and benefits of minimally invasive Cancer surgery.
Dr Dinesh Mavinahalli Gangaiah performs minimally invasive Cancer surgery at ARC Cancer Hospital, Bengaluru, a dedicated Cancer centre whose surgical suites are specifically configured for minimally invasive and robotic-assisted Oncological procedures.
The question patients most frequently ask is: is laparoscopic surgery as effective as open surgery for Cancer? The answer, confirmed by multiple large randomised controlled trials across GI, thoracic, and gynaecological Cancers, is yes. Here is the honest, evidence-based comparison:
| Open Surgery | Minimally Invasive Surgery | |
|---|---|---|
| Incision Size | 10 to 30 cm single large incision | 3 to 5 small ports, 5 to 12 mm each |
| Hospital Stay | 7 to 14 days for major GI surgery | 3 to 6 days for equivalent laparoscopic procedure |
| Post-operative Pain | Significant; higher opioid requirement | Substantially less; earlier mobilisation |
| Blood Loss | Higher; transfusion more likely | Significantly reduced; transfusion rarely needed |
| Wound Complications | Higher infection and hernia rates | Lower: smaller incisions |
| Return to Normal Activity | 6 to 12 weeks | 2 to 4 weeks |
| Start of Adjuvant Chemotherapy | Often delayed by prolonged recovery | Earlier start possible: significant Oncological benefit |
| Visualisation Quality | Direct, unaided naked eye in a large field | HD camera: magnified, detailed, better in confined spaces |
| Oncological Outcomes (Cancer Clearance, Survival) | The historical gold standard | Equivalent: confirmed in multiple RCTs across all Cancer sites |
| Suitable for | All patients; complex locally advanced tumours requiring vascular reconstruction | Most patients with resectable Cancer; some advanced cases may require open approach, discussed at Tumour Board |
The Oncological outcomes, Cancer clearance at resection margins, lymph node harvest, and long-term disease-free and overall survival, are consistently equivalent between open and minimally invasive surgery across all Cancer sites studied in randomised trials. The benefits of minimally invasive surgery are entirely additive, they improve the patient experience without reducing the Cancer control achieved.
The following minimally invasive Cancer procedures are performed by Dr Dinesh Mavinahalli Gangaiah at ARC Cancer Hospital, Bengaluru. Every procedure listed here is supported by the surgical infrastructure available at ARC Cancer Hospital and has been confirmed against the hospital’s service capabilities:
| Cancer / Procedure | MIS Approach | Performed at ARC Cancer Hospital |
|---|---|---|
| Stomach Cancer (Gastrectomy) | Laparoscopic total or distal gastrectomy with D2 lymph node dissection | Performed in ARC Cancer Hospital’ laparoscopic OT suite; intraoperative frozen section at ARC Diagnostics for margin confirmation; D2 nodal yield confirmed by ARC Diagnostics on-campus pathology |
| Colorectal Cancer (Colectomy / Anterior Resection) | Laparoscopic right and left hemicolectomy; laparoscopic anterior resection and low anterior resection; laparoscopic total mesorectal excision (TME) for rectal Cancer | Laparoscopic colorectal Oncological resections performed at ARC Cancer Hospital; robotic TME available for rectal Cancer requiring better pelvic access |
| Oesophageal Cancer (Oesophagectomy) | Minimally invasive oesophagectomy (MIO): thoracoscopic chest phase and laparoscopic abdominal phase (Ivor Lewis or McKeown approach) | Dr Dinesh’s unique GI + Thoracic expertise; thoracoscopic and laparoscopic phases performed at ARC’s OT suite; one of few surgeons in Bengaluru offering MIO from a single-surgeon perspective |
| Pancreatic Cancer (Whipple / Distal Pancreatectomy) | Laparoscopic pancreaticoduodenectomy (Whipple); laparoscopic distal pancreatectomy with splenectomy | Complex laparoscopic pancreatic surgery performed at ARC Cancer Hospital; robotic platform available for the delicate pancreaticojejunostomy and hepaticojejunostomy anastomoses |
| Liver Cancer (Liver Resection) | Laparoscopic segmentectomy, hemihepatectomy, and non-anatomical liver resection | Laparoscopic liver resection performed at ARC Cancer Hospital; intraoperative ultrasound for margin assessment; ARC Diagnostics pathology for resection margin confirmation |
| Lung Cancer (VATS Lobectomy / Segmentectomy) | VATS lobectomy: video-assisted thoracoscopic surgery; VATS segmentectomy for selected early tumours; VATS wedge resection; systematic mediastinal lymph node dissection | VATS thoracic procedures performed at ARC Cancer Hospital OT; thoracoscopic equipment confirmed; robotic thoracic surgery available for mediastinal and complex hilar cases |
| Thymic and Mediastinal Tumours (VATS / Robotic Thymectomy) | Thoracoscopic or robotic thymectomy for thymoma; VATS mediastinal biopsy; VATS mediastinal mass resection | VATS mediastinal procedures at ARC Cancer Hospital; robotic thymectomy for anterior mediastinal tumours |
| Gynaecological Cancers (Hysterectomy / Staging) | Laparoscopic or robotic total hysterectomy with bilateral salpingo-oophorectomy; pelvic and para-aortic lymph node dissection; laparoscopic radical hysterectomy for cervical Cancer | Laparoscopic and robotic gynaecological Oncological procedures at ARC Cancer Hospital; ARC Diagnostics on-campus pathology for frozen section margin assessment |
| Kidney Cancer (Nephrectomy) | Laparoscopic or robotic partial nephrectomy (nephron-sparing); laparoscopic radical nephrectomy | Laparoscopic and robotic nephrectomy at ARC Cancer Hospital; pre-operative staging on ARC Diagnostics CT (GE Optima CT540) and MRI (Time Medical MICA 1.5T HTS) |
| Bladder Cancer (Cystectomy / TURBT) | Laparoscopic or robotic radical cystectomy with urinary diversion; TURBT (transurethral resection, endoscopic) | Laparoscopic and robotic radical cystectomy at ARC Cancer Hospital; TURBT performed endoscopically in the ARC OT suite |
| Prostate Cancer (Prostatectomy) | Laparoscopic or robotic radical prostatectomy; nerve-sparing prostatectomy; pelvic lymph node dissection | Laparoscopic and robotic radical prostatectomy at ARC Cancer Hospital; pre-operative staging with mpMRI on ARC Diagnostics Time Medical MICA 1.5T HTS |
| Adrenal Tumours (Adrenalectomy) | Laparoscopic adrenalectomy for benign and functional adrenal tumours; phaeochromocytoma with pre-operative alpha-blockade preparation | Laparoscopic adrenalectomy at ARC Cancer Hospital; pre-operative biochemical preparation protocol coordinated through ARC Cancer Hospital |
| Upper Tract Urothelial Carcinoma (Nephroureterectomy) | Laparoscopic radical nephroureterectomy (RNU) with bladder cuff excision | Laparoscopic RNU at ARC Cancer Hospital; post-operative intravesical chemotherapy coordinated through urology and medical Oncology |
| Soft Tissue Sarcoma (Limb-Sparing Excision) | Wide excision with limb salvage; laparoscopic or minimal access approach for selected deep tumours where MIS access is appropriate | Wide excision for soft tissue sarcoma at ARC Cancer Hospital; intraoperative frozen section for margin assessment at ARC Diagnostics |
After a laparoscopic gastrectomy for stomach Cancer, the average hospital stay is 4 to 6 days. After an open gastrectomy for the same Cancer, it is 10 to 14 days. The difference is not cosmetic: it represents the absence of a large abdominal wound, the preservation of abdominal wall musculature, and the avoidance of the ileus (gut paralysis) that commonly follows open abdominal surgery. For patients, a shorter hospital stay means less exposure to hospital-acquired infection, earlier return to home and family, and lower total hospitalisation costs.
The most common complaint after open Cancer surgery is pain, from the incision, from the rib-spreading of thoracotomy, from the wound healing over weeks. Minimally invasive surgery, with its 5 to 12 mm ports rather than 15 to 30 cm incisions, eliminates the primary source of this pain. Most laparoscopic surgery patients require only oral pain medication after the first 24 hours; most open surgery patients require parenteral opioids for 3 to 5 days. Less pain means earlier mobilisation, earlier deep breathing, and a shorter path to recovery.
For Cancers where surgery is followed by chemotherapy or radiation, colorectal Cancer, stomach Cancer, lung Cancer, ovarian Cancer, gynaecological Cancers, the timing of adjuvant treatment matters. Most Oncological guidelines recommend starting adjuvant chemotherapy within 4 to 8 weeks of surgery. Open surgery patients frequently struggle to begin within this window because of prolonged wound healing and recovery. Minimally invasive surgery patients, with their 2 to 3 week recovery, routinely begin adjuvant chemotherapy within the optimal window, and the evidence suggests this timing benefit translates into better long-term outcomes.
Laparoscopic and VATS procedures consistently produce less intraoperative blood loss than equivalent open procedures. The pneumoperitoneum pressure reduces venous oozing. The magnified camera view allows precise identification and control of blood vessels before division. The energy devices used in laparoscopic surgery provide better haemostasis compared to open surgical techniques. The practical result: most minimally invasive Cancer surgery patients do not require blood transfusion. This matters because transfusion in Cancer surgery is associated with immunosuppression and, in some studies, with worse long-term Cancer outcomes.
A common misconception is that operating through small ports, without direct vision, reduces the surgeon’s ability to see and control the surgical field. In practice, the opposite is often true. The laparoscopic camera provides a magnified, high-definition view of the anatomy that the naked eye in an open incision cannot match, particularly in confined spaces like the pelvis, the mediastinum, and the hepatic hilum. Small blood vessels, tissue planes, and nerve structures that are difficult to see in open surgery are clearly visible on the monitor. This visualisation advantage is one of the reasons minimally invasive surgery achieves equivalent or better margin clearance and lymph node harvest compared to open surgery in multiple studies.
Wound infection, wound dehiscence (opening), and incisional hernia are significant complications of open Cancer surgery, occurring in 5 to 15% of patients depending on the procedure, the patient’s nutritional status, and whether post-operative chemotherapy or radiation compromises wound healing. Minimally invasive surgery, with its 5 to 12 mm port sites rather than large laparotomy wounds, has lower wound complication rates. In the Indian climate, where wound infection is a particular concern, this advantage is clinically significant.
Minimally invasive surgery is the preferred approach for most eligible patients with resectable GI, thoracic, gynaecological, and urological Cancers at ARC Cancer Hospital. However, not every patient or every tumour is suitable for a minimally invasive approach, and at ARC Cancer Hospital, this decision is never made by the patient, the surgeon, or the marketing material. It is made at the Multidisciplinary Tumour Board.
When open surgery is indicated, and it is, for a meaningful proportion of complex Cancer cases, Dr Dinesh Mavinahalli Gangaiah performs open Cancer surgery with the same Oncological precision. The minimally invasive approach is the preference and the standard where it is safe and appropriate. It is never forced when it is not.
Dr Dinesh Mavinahalli Gangaiah performs minimally invasive Cancer surgery at ARC Cancer Hospital, Bengaluru, Dr MH Marigowda Road, Lakkasandra, Hombegowda Nagar, Bengaluru, 560027. He consults patients from across Bengaluru and Karnataka, and from Tamil Nadu, Andhra Pradesh, Telangana, and Kerala.
Yes: this is the most important question about minimally invasive Cancer surgery, and the answer is confirmed by multiple large randomised controlled trials. Laparoscopic Cancer surgery achieves equivalent margin clearance (removing all Cancer tissue with clear margins), equivalent lymph node harvest (collecting the same number of nodes for staging), and equivalent long-term Cancer-free survival compared to open surgery. The CLASS-01 trial for gastric Cancer, the CLASICC trial for colorectal Cancer, and multiple studies on laparoscopic hysterectomy for endometrial Cancer all confirm this equivalence. The minimally invasive approach changes the access route, not the Oncological principles or outcomes. Dr Dinesh Mavinahalli Gangaiah applies the same Oncological resection standards through a laparoscope that he would through an open incision.
Recovery is significantly shorter after minimally invasive surgery. The typical timelines for laparoscopic vs open Cancer surgery: hospital stay, 3 to 6 days (laparoscopic) vs 7 to 14 days (open) for major GI procedures; return to light activity, 2 weeks (laparoscopic) vs 4 to 6 weeks (open); return to full normal activity, 3 to 4 weeks (laparoscopic) vs 8 to 12 weeks (open). For patients who need post-operative chemotherapy, this shorter recovery is not just a comfort issue, starting chemotherapy earlier, within the recommended 4 to 8 week window, is associated with better Oncological outcomes.
Absolutely, and this is a very reasonable question. Not every Cancer can be operated laparoscopically, and some cases that were appropriately offered open surgery at one centre may be suitable for a minimally invasive approach at a centre with dedicated laparoscopic Oncology expertise. Factors that determine laparoscopic suitability include tumour size and location, stage, prior surgery, patient anatomy, and surgeon experience. Dr Dinesh Mavinahalli Gangaiah offers consultations specifically for patients seeking assessment of their suitability for minimally invasive Cancer surgery. Please bring all available imaging (CT, MRI, PET CT), biopsy reports, and previous surgical records to your consultation at ARC Cancer Hospital.
ARC Cancer Hospital’ operation theatres are equipped with state-of-the-art laparoscopic surgical systems, high-definition camera towers, CO2 insufflation equipment, and advanced energy devices (ultrasonic dissectors and advanced bipolar platforms) for precise tissue handling and haemostasis. A robotic surgical system is available for procedures where robotic assistance provides meaningful clinical advantage over conventional laparoscopy, including complex pelvic procedures, oesophageal surgery, and mediastinal tumour resection. The operating theatre is supported by on-campus imaging at ARC Diagnostics (GE Optima CT540 for staging CT, Time Medical MICA 1.5T HTS MRI for soft tissue staging, GE Discovery IQ Gen 2 PET CT for metabolic staging) and by on-campus pathology for intraoperative frozen section margin assessment.
Minimally invasive Cancer surgery leaves 3 to 5 small scars from the port sites, each typically 5 to 12 mm. These are significantly smaller than the 10 to 30 cm scars left by open Cancer surgery. Over time, the port site scars fade substantially and are often barely visible at 12 months. For patients concerned about surgical scars, particularly younger patients or those undergoing abdominal or thoracic Cancer surgery, minimally invasive surgery offers a meaningful cosmetic advantage alongside its functional and recovery benefits.
Conversion from laparoscopic to open surgery, completing the procedure through a larger incision after starting laparoscopically, occurs in a small proportion of cases, typically when intraoperative findings (unexpected adhesions, abnormal anatomy, bleeding that is difficult to control laparoscopically) make laparoscopic completion unsafe or incomplete. Conversion is not a complication: it is a clinical decision made in the patient’s best interest, and it is always discussed as a possibility before any minimally invasive procedure. In Dr Dinesh Mavinahalli Gangaiah’s practice, the conversion rate is low as a result of careful patient selection and preoperative planning, but every patient consenting to laparoscopic Cancer surgery is informed that conversion is possible.
Laparoscopic surgery is used for many Cancers of the stomach, colon, rectum, liver and gallbladder, for selected pancreatic Cancers, for uterine, cervical and early ovarian Cancers, and for kidney Cancer. In the chest the same keyhole approach is called VATS. Whether it suits you depends on the type of Cancer, its stage and your health, and this is decided before surgery.
This website gives general information about Cancer and Cancer surgery. It is not medical advice for your situation and does not replace a consultation with a qualified doctor.
Copyright© 2026 Dr Dinesh Mavinahalli Gangaiah. Privacy Policy · Terms & Conditions
